Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Canopy Growth Teams Up With NHL Alumni To Test Medical Applications Of Cannabis

By Investing.com (Brenda O'Farrell)Stock MarketsMar 04, 2019 10:41
ca.investing.com/analysis/canopy-growth-teams-up-with-nhl-alumni-to-test-medical-applications-of-cannabis-200198279
Canopy Growth Teams Up With NHL Alumni To Test Medical Applications Of Cannabis
By Investing.com (Brenda O'Farrell)   |  Mar 04, 2019 10:41
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Just when you thought the story about the expanding legalized cannabis market in this country wasn’t Canadian enough, they’ve decided to throw a few professional hockey players into the mix.

That’s right. The National Hockey League’s Alumni Association is teaming up with Ontario-based Canopy Growth to launch a clinical research partnership to study the effectiveness of using cannabinoids in the treatment of neurological diseases among former NHL players who have suffered concussions. It’s a first-of-its kind partnership.

In a statement released on Saturday, March 2, Canopy Growth, the largest marijuana producer by market cap, explains the study will aim to “establish the medicinal value of cannabis when combined with other proven treatments amongst the highly-afflicted group of elite athletes.”

About 100 former NHL players will take part in the study that will be conducted by NEEKA Health Canada. Some participants will be given pills containing CBD compounds, while others will be given placebos. The affects will be monitored using a variety of tests, including MRI brain scans, and software to measure speech and writing patterns, memory and emotional state. CBD is a cannabis derivative. But unlike marijuana, CBD doesn’t have THC, the psychoactive ingredient that gives a user a so-called high.

The study is scheduled to begin this summer and take a year to complete.

In an interview in Toronto, Canopy Growth co-CEO Bruce Linton said the star-power of NHL players will help build awareness of the potential for medical cannabis.

In another partnership announced last week, Canopy Growth signed a deal with U.S. lifestyle guru Martha Stewart. The former TV host and DYI celebrity will have an advisory role in the development of a line of cannabinoids edibles and other related products. The move is widely viewed as means to help promote the awareness of CBD compounds and their potential benefits.

Canopy Growth Teams Up With NHL Alumni To Test Medical Applications Of Cannabis
 

Related Articles

Canopy Growth Teams Up With NHL Alumni To Test Medical Applications Of Cannabis

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email